{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:39:31Z","timestamp":1773423571252,"version":"3.50.1"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The m.3243A&amp;gt;G mutation in the MT-TL1 gene is the most common mtDNA mutation. The mutation can lead to a spectrum of conditions, including diabetes, hearing loss, heart and muscle involvement, encephalopathy and epilepsy, gastrointestinal problems, and vision impairment, often occurring concurrently\u2014collectively referred to as MELAS (mitochondrial encephalopathy lactic acidosis and stroke-like episodes) syndrome. Currently, it has been reported that the ocular manifestations of m.3243A&amp;gt;G include posterior subcapsular cataract, ptosis, extraocular muscle paralysis, and retinitis pigmentosa, among which retinitis pigmentosa is the most common ocular manifestation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The ocular manifestations of a 10-month-old infant with mitochondrial MT-TL1 gene m.3243A&amp;gt;G mutation detected by genetic testing due to developmental delay were reported.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Ocular examination revealed Schiotz tonometry conversion values of 5.5\/6 in the right eye (OD) and 5.5\/4 in the left eye (OS) for intraocular pressure. Cycloplegic refraction measured +9.50 DS\/\u22122.00 DC\u2009\u00d7\u2009110\u00b0 (OD) and +4.00 DS\/\u22121.75 DC\u2009\u00d7\u200930\u00b0 (OS). Anterior segment evaluation showed an irregular vertically oval pupil with absence of the temporal iris OD and a fusiform pupil OS, with no other anterior segment abnormalities detected in either eye. Fundus examination demonstrated clear optic disc boundaries bilaterally and a cup-to-disc (C\/D) ratio of 0.3. Sodium fluorescein angiography revealed an intact retina without evidence of peripheral vascular leakage.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Iris defect in a infant caused by m.3243A&amp;gt;G mutation was reported, which complements the ocular signs of this mutation and provides a new aspect for eye screening.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2025.1573886","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T05:27:05Z","timestamp":1755754025000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Abnormal pupils caused by the mitochondrial MT-TL1 gene m.3243A&gt;G mutation"],"prefix":"10.3389","volume":"13","author":[{"given":"Yujing","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enzhong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e264055","DOI":"10.1136\/bcr-2024-264055","article-title":"Psychiatric manifestations in a patient with a pathogenic variant in the MT-TL1 gene associated with MELAS","volume":"18","author":"Gujrati","year":"2025","journal-title":"BMJ Case Rep"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.12740\/pp\/24062","article-title":"[Psychiatric disturbances in five patients with MELAS syndrome]","volume":"48","author":"Magner","year":"2014","journal-title":"Psychiatr Pol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.survophthal.2021.02.008","article-title":"Mitochondrial DNA A3243g variant-associated retinopathy: current perspectives and clinical implications","volume":"66","author":"Coussa","year":"2021","journal-title":"Surv Ophthalmol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e165937","DOI":"10.1172\/jci.insight.165937","article-title":"Multimodal single-cell analysis of nonrandom heteroplasmy distribution in human retinal mitochondrial disease","volume":"8","author":"Mullin","year":"2023","journal-title":"JCI insight"},{"key":"B5","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/cge.14605","article-title":"The clinical and genetic Spectrum of mitochondrial diseases in China: a multicenter retrospective cross-sectional study","volume":"106","author":"Zhao","year":"2024","journal-title":"Clin Genet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"871","DOI":"10.4045\/tidsskr.21.0729","article-title":"[Mitochondrial disease caused by the M.3243a>G mutation]","volume":"142","author":"Varhaug","year":"2022","journal-title":"Tidsskr Nor Laegeforen"},{"key":"B7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nrendo.2016.151","article-title":"Mitochondrial disease and endocrine dysfunction","volume":"13","author":"Chow","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"S103","DOI":"10.2337\/diabetes.53.2007.s103","article-title":"Mitochondrial diabetes: molecular mechanisms and clinical presentation","volume":"53","author":"Maassen","year":"2004","journal-title":"Diabetes"},{"key":"B9","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/s12967-024-05275-8","article-title":"Lysosomal dysfunction and overload of nucleosides in thymidine phosphorylase deficiency of MNGIE","volume":"22","author":"Du","year":"2024","journal-title":"J Transl Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"253","DOI":"10.15698\/cst2018.10.158","article-title":"Mitochondrial stress management: a dynamic journey","volume":"2","author":"Valera-Alberni","year":"2018","journal-title":"Cell Stress"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1164287","DOI":"10.3389\/fphys.2023.1164287","article-title":"Complex I deficiency in M.3243a>G fibroblasts is alleviated by reducing NADH accumulation","volume":"14","author":"Liufu","year":"2023","journal-title":"Front Physiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"6409","DOI":"10.1038\/s41467-021-26746-2","article-title":"Constitutive activation of the Pi3k-akt-Mtorc1 pathway sustains the M.3243a>G MTDNA mutation","volume":"12","author":"Chung","year":"2021","journal-title":"Nat Commun"},{"key":"B13","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.survophthal.2019.11.001","article-title":"Mitochondrial disorders and the eye","volume":"65","author":"Kisilevsky","year":"2020","journal-title":"Surv Ophthalmol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/s0161-6420(13)31404-3","article-title":"Ocular pathology of Melas syndrome with mitochondrial DNA nucleotide 3243 point mutation","volume":"100","author":"Rummelt","year":"1993","journal-title":"Ophthalmology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1136\/bjo.2008.154187","article-title":"Ophthalmological findings in children and young adults with genetically verified mitochondrial disease","volume":"94","author":"Gr\u00f6nlund","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e1955","DOI":"10.1002\/mgg3.1955","article-title":"Molecular and neurological features of MELAS syndrome in paediatric patients: a case series and review of the literature","volume":"10","author":"Seed","year":"2022","journal-title":"Mol Genet Genomic Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.ophtha.2015.10.025","article-title":"Gene therapy for leber hereditary optic neuropathy: initial results","volume":"123","author":"Feuer","year":"2016","journal-title":"Ophthalmology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ebiom.2016.07.002","article-title":"Long-term outcomes of gene therapy for the treatment of leber\u2019s hereditary optic neuropathy","volume":"10","author":"Yang","year":"2016","journal-title":"EBioMedicine"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1573886\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T05:27:08Z","timestamp":1755754028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1573886\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":18,"alternative-id":["10.3389\/fped.2025.1573886"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1573886","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"article-number":"1573886"}}